Salbiya, Baby Girl -.
HRN: 27-27-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/21/2025
06/28/2025
IV
12mg
Q24H
PSNB
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Bloodstream Compliance to guidelines: